Koninklijke DSM NV Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Koninklijke DSM NV last-minute Real Value cannot be determined due to lack of data. The latest price of Koninklijke DSM NV is $0.0. Our model forecasts the value of Koninklijke DSM NV from analyzing the firm fundamentals such as Profit Margin of 0.11 %, current valuation of 23.38 B, and Return On Equity of 0.12 as well as examining its technical indicators and probability of bankruptcy.
Koninklijke DSM Total Value Analysis
Koninklijke DSM NV is now forecasted to have takeover price of 23.38 B with market capitalization of 22.49 B, debt of 2.84 B, and cash on hands of 1.63 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Koninklijke DSM fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.38 B | 22.49 B | 2.84 B | 1.63 B |
Koninklijke DSM Investor Information
About 57.0% of the company shares are owned by institutional investors. The book value of Koninklijke DSM was now reported as 56.38. The company has Price/Earnings To Growth (PEG) ratio of 2.88. Koninklijke DSM NV recorded earning per share (EPS) of 6.71. The entity last dividend was issued on the 4th of August 2022. The firm had 2:1 split on the 5th of September 2005. Koninklijke DSM NV is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Koninklijke DSM Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Koninklijke DSM has an asset utilization ratio of 57.48 percent. This implies that the Company is making $0.57 for each dollar of assets. An increasing asset utilization means that Koninklijke DSM NV is more efficient with each dollar of assets it utilizes for everyday operations.Koninklijke DSM Ownership Allocation
Koninklijke DSM NV maintains a total of 172.97 Million outstanding shares. Over half of Koninklijke DSM's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Koninklijke DSM Profitability Analysis
The company reported the revenue of 9.2 B. Net Income was 1.68 B with profit before overhead, payroll, taxes, and interest of 3.16 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Koninklijke DSM's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Koninklijke DSM and how it compares across the competition.
Koninklijke DSM Growth Indicators
Investing in growth stocks can be very risky. If the company such as Koninklijke DSM does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 173 M | |
| Quarterly Earnings Growth Y O Y | -0.553 | |
| Forward Price Earnings | 29.4985 | |
| Retained Earnings | 8.5 B |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Koninklijke Pink Sheet
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |